Practice Management News

The FDA announced that drug manufacturers will now be required to include information about naloxone in prescribing information for opioids and medications to treat opioid use disorders.

Our practice was shuttered at the beginning of the COVID-19 pandemic to all but emergent patients.

2020 was supposed to be the year of vision, which we approached with great excitement. Never in our wildest dreams did we expect to face what we’re experiencing now. And who knows what the future will bring?

Healio and Healio LIVE received seven APEX awards, including one Grand Award — the highest recognition — presented to Infectious Diseases in Children.

In a previous column, we discussed several steps physicians should consider to shield their families’ finances during the COVID-19 crisis.

Billie Holiday recorded “Strange Fruit” in 1937.

More than 4,000 people have signed an online petition urging members of Congress to implement a national mandate that requires all Americans to wear masks or face coverings in public to stop the spread of COVID-19.

Several trials exploring radiation’s potential as a treatment for critically ill patients with COVID-19 are underway in the United States.

The FDA issued an emergency use authorization for CLEWICU, an artificial intelligence-based platform that identifies several COVID-19 complications hours before they occur, the manufacturer said in a press release.

Dispensed prescriptions of hydroxychloroquine in the U.S. increased 86.2%, while such prescriptions of chloroquine increased 158.6% from February to March 2020, data show.